Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

Nehme Z, Muller M, Brochon J, Crouchet E, Jühling F, Messé M, Meiss-Heydmann L, Moehlin J, Desert R, Del Zompo F, Thumann C, Lupberger J, Roehlen N, Felli E, Pessaux P, Venkatasamy A, Marchand P, Onea MA, Iacone R, Meyer M, Toso A, Bardeesy N, Sia D, Llovet JM, Hoshida Y, Goyal L, Fernández-Vaquero M, Ranvir VP, Heikenwälder M, Ostyn T, Roskams T, Laquerriere P, Mailly L, Schuster C, Baumert TF

Open source

DOI
10.1126/scitranslmed.adp2595
Published
2026 Jun 3
Container
Science translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.adp2595,
  title = {Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.},
  author = {Nehme Z and Muller M and Brochon J and Crouchet E and Jühling F and Messé M and Meiss-Heydmann L and Moehlin J and Desert R and Del Zompo F and Thumann C and Lupberger J and Roehlen N and Felli E and Pessaux P and Venkatasamy A and Marchand P and Onea MA and Iacone R and Meyer M and Toso A and Bardeesy N and Sia D and Llovet JM and Hoshida Y and Goyal L and Fernández-Vaquero M and Ranvir VP and Heikenwälder M and Ostyn T and Roskams T and Laquerriere P and Mailly L and Schuster C and Baumert TF},
  year = {2026},
  journal = {Science translational medicine},
  doi = {10.1126/scitranslmed.adp2595},
  url = {https://doi.org/10.1126/scitranslmed.adp2595}
}

RIS

TY  - JOUR
TI  - Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.
AU  - Nehme Z
AU  - Muller M
AU  - Brochon J
AU  - Crouchet E
AU  - Jühling F
AU  - Messé M
AU  - Meiss-Heydmann L
AU  - Moehlin J
AU  - Desert R
AU  - Del Zompo F
AU  - Thumann C
AU  - Lupberger J
AU  - Roehlen N
AU  - Felli E
AU  - Pessaux P
AU  - Venkatasamy A
AU  - Marchand P
AU  - Onea MA
AU  - Iacone R
AU  - Meyer M
AU  - Toso A
AU  - Bardeesy N
AU  - Sia D
AU  - Llovet JM
AU  - Hoshida Y
AU  - Goyal L
AU  - Fernández-Vaquero M
AU  - Ranvir VP
AU  - Heikenwälder M
AU  - Ostyn T
AU  - Roskams T
AU  - Laquerriere P
AU  - Mailly L
AU  - Schuster C
AU  - Baumert TF
PY  - 2026
JO  - Science translational medicine
DO  - 10.1126/scitranslmed.adp2595
UR  - https://doi.org/10.1126/scitranslmed.adp2595
ER  - 

APA

Z, N., M, M., J, B., E, C., F, J., M, M., L, M., J, M., R, D., F, D. Z., C, T., J, L., N, R., E, F., P, P., A, V., P, M., MA, O., R, I., M, M., A, T., N, B., D, S., JM, L., Y, H., L, G., M, F., VP, R., M, H., T, O., T, R., P, L., L, M., C, S., & TF, B. (2026). Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.. Science translational medicine. https://doi.org/10.1126/scitranslmed.adp2595

Source records